• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Risk of dementia with air pollution exposure amplified in patients with heart disease

byAlex ChanandRavi Shah, MD MBA
April 16, 2020
in Cardiology, Chronic Disease, Neurology, Psychiatry, Public Health
Reading Time: 2 mins read
Risk of dementia with air pollution exposure amplified in patients with heart disease
Share on FacebookShare on Twitter

1. Exposure to higher levels of air pollutants was associated with increased dementia incidence, with the 5 years preceding onset being the most impactful.

2. The association between dementia and air pollutant exposure was amplified in patients with cardiovascular disease, specifically heart failure and ischemic heart disease.

Evidence Rating: 2 (Good)

With increasing rates of dementia and no curative treatment being available, identification of risk factors and possible preventative measures continues to be a priority in addressing the issue. A ir pollution has recently been identified as risk factor for the development of dementia. Currently, the role of cardiovascular disease (CVD) in this association is unknown. In this retrospective cohort study, researchers analyzed the data of 2977 participants from the ongoing Swedish National Study on Aging and Care in Kungsholmen (SNAC-K) to address this knowledge gap, hypothesizing that CVD may mediate and strengthen the association between air pollution and dementia incidence. Patients were recruited between 2001 to 2004, with follow-up up to 2013. Particulate matter and nitrogen oxide were identified as the two major air pollutants with yearly assessment, and dementia and CVD (including atrial fibrillation, ischemic heart disease, stroke, heart failure) were identified as main outcomes. Mean age of participants was 74.1 years, and 364 incident cases of dementia were identified during follow up, 72.3% of which were women.  A higher hazard of dementia was found per interquartile range (IQR) difference of particulate matter ≤2.5 μm (PM2.5) (HR, 1.54; 95% CI, 1.33-1.78; IQR difference, 0.88 μg/m3) and nitrogen oxide (NOx) (HR, 1.14; 95% CI, 1.01-1.29; IQR difference, 8.35 μg/m3) concentrations during the 5 years preceding onset, though no association was found during the 6 to 11 years before the event. Interestingly, higher risk of dementia were associated with exposure to PM2.5 and NOx in persons with heart failure (interaction HR, 1.38 [95% CI, 1.06-1.81] and 1.35 [95% CI, 1.05-1.72], respectively) and ischemic heart disease (interaction HR, 1.13 [95% CI, 0.90-1.48] and 1.22 [95% CI, 0.95-1.60], respectively), but not for strokes and atrial fibrillation. Instead, stroke appeared to be the primary intermediate condition, accounting for 49.4% of air pollution-related dementia cases. In terms of study implications, these findings suggest reduction of air pollution as a potential means to reduce future dementia incidence, and reemphasizes the importance of optimal CVD management and prevention.

Click to read the study in JAMA Neurology

Image: PD

RELATED REPORTS

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasedementiaheart failurenitric oxideparticulate matter
Previous Post

Insurance coverage rates among poor new mothers increased after Medicaid expansion

Next Post

Results from remdesivir compassionate use study for severe COVID-19

RelatedReports

Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Next Post
Radiological findings of COVID-19 pneumonia in Wuhan, China

Results from remdesivir compassionate use study for severe COVID-19

Addition of claims-based frailty index enhances current Medicare cost prediction model

The SOLO1 trial: Olaparib significantly delays progression of advanced ovarian cancer

Decreased risk of ovarian cancer in women who have breastfed

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.